Stocks expected to have increasing option volume: ORCL ADM CASY MTN KSS ACAD ASAN NVDA AMD ARM SMCI IRBT ONON
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Oracle (ORCL) PT Raised to $142 at CFRA
March 12, 2024 9:30 AM EDTCFRA analyst Angelo Zino raised the price target on Oracle (NYSE: ORCL) to $142.00 (from $130.00) while maintaining a Hold rating.
The analyst comments "We increase our 12-month target to $142 from $130, on a higher revised P/E of 21x our CY 25 EPS estimate of... More
Oracle (ORCL) PT Raised to $145 at TD Cowen
March 12, 2024 6:39 AM EDTTD Cowen analyst Derrick Wood raised the price target on Oracle (NYSE: ORCL) to $145.00 (from $130.00) while maintaining a Outperform rating.
The analyst comments "ORCL reported a solid 3Q w/ total rev growth of 7% cc in line w/ guide of 6-8%, incl.... More
Oracle (ORCL) PT Raised to $145 at Evercore ISI, 'Outlook Less Cloudy'
March 12, 2024 5:02 AM EDTEvercore ISI analyst Kirk Materne raised the price target on Oracle (NYSE: ORCL) to $145.00 (from $130.00) while maintaining a Outperform rating.
The analyst comments "Bottom line: Oracle shares are up nicely in the after-market as OCI revenue growth of 52% in c/c was in line with our expectations and importantly, F4Q guidance infers OCI growth of ~40% against a very difficult compare. The other highlight was the strength in RPO, which grew 41% in c/c excl. Cerner to $80bn and cRPO growth of ~15%. Notably, OCI revenue grew $175mn sequentially vs. $100mn last quarter.... More
Oracle (ORCL) PT Raised to $150 at Jefferies, 'F3Q: Base Hit, One Runner On'
March 12, 2024 5:01 AM EDTJefferies analyst Brent Thill raised the price target on Oracle (NYSE: ORCL) to $150.00 (from $145.00) while maintaining a Buy rating.
The analyst comments "ORCL made contact in F3Q after a disappointing F1H led by better-than-expected OCI results and 29% backlog growth. While... More
Guggenheim Reviews 'Best Idea' Oracle (ORCL) Earnings
March 12, 2024 4:59 AM EDTGuggenheim analyst John DiFucci reiterated a Buy rating and $150.00 price target on Oracle (NYSE: ORCL)
The analyst comments "ORCL surprised to the upside in OCI, and although Cloud ex. Cerner was at the low end of guidance, it was probably at least what the buy side was looking for. ORCLs results were a stark contrast to the recent decelerating business momentum of most Software names (as measured by a 2-year stack of New ARR growth see Exhibit 1). New ARR for organic Cloud accelerated to about 28% growth, and New ARR for IaaS... More
Oracle (ORCL) PT Raised to $159 at Bernstein, 'Solid quarter, positive outlook'
March 12, 2024 4:25 AM EDTBernstein analyst Mark Moerdler raised the price target on Oracle (NYSE: ORCL) to $159.00 (from $147.00) while maintaining a Outperform rating.
The analyst comments "Oracle delivered a good quarter, coming in line with expectations on total revenue, driven by a beat in cloud and software. The company also delivered a nice operating margin improvement. More importantly, Oracle provided a solid... More
